Peripartum cocaine use and adverse pregnancy outcome

Bertis B. Little, Laura M. Snell, Kenneth J. Trimmer, Susan M. Ramin, Fred Ghali, Craig A. Blakely, Andrea Garret

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The objective of the study was to analyze possible adverse effects of peripartum cocaine use on maternal and fetal outcomes. Informed consent was given by 720 (97%) of 740 women who delivered consecutively at a large urban public hospital to test an umbilical cord blood sample for the presence of non-medically administered drugs of abuse and alcohol and to be interviewed for the study. Samples were tested for the presence of a cocaine metabolite (benzoylecgonine-BZE) by radioimmunoassay. The presence of other substances of abuse (alcohol, methamphetamine, opiates) resulted in exclusion from the sample of 143 subjects. Thus, in this cohort analysis, drug-free controls (N = 469) were compared to those positive for cocaine only (N = 108). Peripartum exposure to cocaine only, and no other substances of abuse, was associated with an increased frequency of abruptio placentae (1.9% vs 0% for control, P < 0.004), thick meconium stained amniotic fluid (3.9% vs 0.7% for controls, P < 0.006), premature rupture of membranes (P < 0.02), genitourinary anomalies (OR = 3.6, P < 0.05), abdominal wall defects (OR = 4.4, P < 0.01) and increased frequency of low birth weight (OR = 2.0, P < 0.02). These are important findings because previous studies have been complicated by the confounding effects of other substances of abuse.

Original languageEnglish (US)
Pages (from-to)598-602
Number of pages5
JournalAmerican Journal of Human Biology
Volume11
Issue number5
StatePublished - 1999

Fingerprint

Peripartum Period
cocaine
pregnancy outcome
substance abuse
Pregnancy Outcome
Cocaine
pregnancy
alcohol
drug
abuse
cohort analysis
Substance-Related Disorders
defect
Opiate Alkaloids
rupture
metabolite
alcohols
blood
Alcohols
membrane

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Agricultural and Biological Sciences (miscellaneous)
  • Anthropology

Cite this

Little, B. B., Snell, L. M., Trimmer, K. J., Ramin, S. M., Ghali, F., Blakely, C. A., & Garret, A. (1999). Peripartum cocaine use and adverse pregnancy outcome. American Journal of Human Biology, 11(5), 598-602.

Peripartum cocaine use and adverse pregnancy outcome. / Little, Bertis B.; Snell, Laura M.; Trimmer, Kenneth J.; Ramin, Susan M.; Ghali, Fred; Blakely, Craig A.; Garret, Andrea.

In: American Journal of Human Biology, Vol. 11, No. 5, 1999, p. 598-602.

Research output: Contribution to journalArticle

Little, BB, Snell, LM, Trimmer, KJ, Ramin, SM, Ghali, F, Blakely, CA & Garret, A 1999, 'Peripartum cocaine use and adverse pregnancy outcome', American Journal of Human Biology, vol. 11, no. 5, pp. 598-602.
Little BB, Snell LM, Trimmer KJ, Ramin SM, Ghali F, Blakely CA et al. Peripartum cocaine use and adverse pregnancy outcome. American Journal of Human Biology. 1999;11(5):598-602.
Little, Bertis B. ; Snell, Laura M. ; Trimmer, Kenneth J. ; Ramin, Susan M. ; Ghali, Fred ; Blakely, Craig A. ; Garret, Andrea. / Peripartum cocaine use and adverse pregnancy outcome. In: American Journal of Human Biology. 1999 ; Vol. 11, No. 5. pp. 598-602.
@article{8566c30fd5f34d1c8072b24f44bd5812,
title = "Peripartum cocaine use and adverse pregnancy outcome",
abstract = "The objective of the study was to analyze possible adverse effects of peripartum cocaine use on maternal and fetal outcomes. Informed consent was given by 720 (97{\%}) of 740 women who delivered consecutively at a large urban public hospital to test an umbilical cord blood sample for the presence of non-medically administered drugs of abuse and alcohol and to be interviewed for the study. Samples were tested for the presence of a cocaine metabolite (benzoylecgonine-BZE) by radioimmunoassay. The presence of other substances of abuse (alcohol, methamphetamine, opiates) resulted in exclusion from the sample of 143 subjects. Thus, in this cohort analysis, drug-free controls (N = 469) were compared to those positive for cocaine only (N = 108). Peripartum exposure to cocaine only, and no other substances of abuse, was associated with an increased frequency of abruptio placentae (1.9{\%} vs 0{\%} for control, P < 0.004), thick meconium stained amniotic fluid (3.9{\%} vs 0.7{\%} for controls, P < 0.006), premature rupture of membranes (P < 0.02), genitourinary anomalies (OR = 3.6, P < 0.05), abdominal wall defects (OR = 4.4, P < 0.01) and increased frequency of low birth weight (OR = 2.0, P < 0.02). These are important findings because previous studies have been complicated by the confounding effects of other substances of abuse.",
author = "Little, {Bertis B.} and Snell, {Laura M.} and Trimmer, {Kenneth J.} and Ramin, {Susan M.} and Fred Ghali and Blakely, {Craig A.} and Andrea Garret",
year = "1999",
language = "English (US)",
volume = "11",
pages = "598--602",
journal = "American Journal of Human Biology",
issn = "1042-0533",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Peripartum cocaine use and adverse pregnancy outcome

AU - Little, Bertis B.

AU - Snell, Laura M.

AU - Trimmer, Kenneth J.

AU - Ramin, Susan M.

AU - Ghali, Fred

AU - Blakely, Craig A.

AU - Garret, Andrea

PY - 1999

Y1 - 1999

N2 - The objective of the study was to analyze possible adverse effects of peripartum cocaine use on maternal and fetal outcomes. Informed consent was given by 720 (97%) of 740 women who delivered consecutively at a large urban public hospital to test an umbilical cord blood sample for the presence of non-medically administered drugs of abuse and alcohol and to be interviewed for the study. Samples were tested for the presence of a cocaine metabolite (benzoylecgonine-BZE) by radioimmunoassay. The presence of other substances of abuse (alcohol, methamphetamine, opiates) resulted in exclusion from the sample of 143 subjects. Thus, in this cohort analysis, drug-free controls (N = 469) were compared to those positive for cocaine only (N = 108). Peripartum exposure to cocaine only, and no other substances of abuse, was associated with an increased frequency of abruptio placentae (1.9% vs 0% for control, P < 0.004), thick meconium stained amniotic fluid (3.9% vs 0.7% for controls, P < 0.006), premature rupture of membranes (P < 0.02), genitourinary anomalies (OR = 3.6, P < 0.05), abdominal wall defects (OR = 4.4, P < 0.01) and increased frequency of low birth weight (OR = 2.0, P < 0.02). These are important findings because previous studies have been complicated by the confounding effects of other substances of abuse.

AB - The objective of the study was to analyze possible adverse effects of peripartum cocaine use on maternal and fetal outcomes. Informed consent was given by 720 (97%) of 740 women who delivered consecutively at a large urban public hospital to test an umbilical cord blood sample for the presence of non-medically administered drugs of abuse and alcohol and to be interviewed for the study. Samples were tested for the presence of a cocaine metabolite (benzoylecgonine-BZE) by radioimmunoassay. The presence of other substances of abuse (alcohol, methamphetamine, opiates) resulted in exclusion from the sample of 143 subjects. Thus, in this cohort analysis, drug-free controls (N = 469) were compared to those positive for cocaine only (N = 108). Peripartum exposure to cocaine only, and no other substances of abuse, was associated with an increased frequency of abruptio placentae (1.9% vs 0% for control, P < 0.004), thick meconium stained amniotic fluid (3.9% vs 0.7% for controls, P < 0.006), premature rupture of membranes (P < 0.02), genitourinary anomalies (OR = 3.6, P < 0.05), abdominal wall defects (OR = 4.4, P < 0.01) and increased frequency of low birth weight (OR = 2.0, P < 0.02). These are important findings because previous studies have been complicated by the confounding effects of other substances of abuse.

UR - http://www.scopus.com/inward/record.url?scp=1842712781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842712781&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 598

EP - 602

JO - American Journal of Human Biology

JF - American Journal of Human Biology

SN - 1042-0533

IS - 5

ER -